Correlation Between Inhibikase Therapeutics and WuXi Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and WuXi Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and WuXi Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and WuXi Biologics, you can compare the effects of market volatilities on Inhibikase Therapeutics and WuXi Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of WuXi Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and WuXi Biologics.

Diversification Opportunities for Inhibikase Therapeutics and WuXi Biologics

0.31
  Correlation Coefficient

Weak diversification

The 3 months correlation between Inhibikase and WuXi is 0.31. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and WuXi Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on WuXi Biologics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with WuXi Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of WuXi Biologics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and WuXi Biologics go up and down completely randomly.

Pair Corralation between Inhibikase Therapeutics and WuXi Biologics

Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.59 times more return on investment than WuXi Biologics. However, Inhibikase Therapeutics is 1.59 times more volatile than WuXi Biologics. It trades about 0.02 of its potential returns per unit of risk. WuXi Biologics is currently generating about -0.04 per unit of risk. If you would invest  412.00  in Inhibikase Therapeutics on September 4, 2024 and sell it today you would lose (136.00) from holding Inhibikase Therapeutics or give up 33.01% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Inhibikase Therapeutics  vs.  WuXi Biologics

 Performance 
       Timeline  
Inhibikase Therapeutics 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Inhibikase Therapeutics are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting forward-looking signals, Inhibikase Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
WuXi Biologics 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in WuXi Biologics are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, WuXi Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Inhibikase Therapeutics and WuXi Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Inhibikase Therapeutics and WuXi Biologics

The main advantage of trading using opposite Inhibikase Therapeutics and WuXi Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, WuXi Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in WuXi Biologics will offset losses from the drop in WuXi Biologics' long position.
The idea behind Inhibikase Therapeutics and WuXi Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.

Other Complementary Tools

Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Stocks Directory
Find actively traded stocks across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device